Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    glycomimetics
Show Display Options
Rank Status Study
1 Recruiting A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: GMI-1271
2 Recruiting Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: GMI-1271
3 Completed Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers
Condition: Healthy Adult Subjects
Interventions: Drug: GMI-1271;   Drug: Placebo
4 Recruiting Preventing Fucose-dependent Binding of Aspergillus and Pseudomonas to Lung Mucin
Condition: Cystic Fibrosis
Intervention:
5 Recruiting Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers
Condition: Healthy
Interventions: Drug: GMI-1359;   Drug: Placebo
6 Recruiting Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
Condition: Deep Venous Thrombosis
Interventions: Drug: GMI-1271;   Drug: Enoxaparin Sodium (Lovenox®)
7 Recruiting A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects
Condition: Healthy Volunteers
Interventions: Drug: GMI-1271;   Drug: Filgrastim;   Drug: Placebo Injection;   Drug: Placebo Infusion
8 Active, not recruiting Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
Condition: Healthy Volunteers
Interventions: Drug: GMI-1271;   Drug: Placebo;   Drug: Enoxaparin Sodium (Lovenox®)
9 Completed
Has Results
Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: GMI-1070
10 Completed Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
Conditions: Sickle Cell Disease;   Vaso-occlusive Crisis;   Pain Crisis
Interventions: Drug: GMI-1070;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.